A patient can either unknowingly overdose, which can cause dizziness, memory loss and fainting, or underdose, which can exacerbate heart failure.
The New Castle, Del.-based drugmaker has not reported any adverse events related to the product removal.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
